Jubilant Pharmova Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 61.90 | 73.70 | 214.40 |
| Operating Expense | 49.20 | 49.80 | 185 |
| Net Profit | 5.80 | 13.60 | 5.30 |
| Net Profit Margin | 9.37 | 18.45 | 2.47 |
| Earning Per Share | 0.36 | 0.86 | 0.33 |
| EBIDTA | 11.50 | 23.20 | 32.30 |
| Effective Tax Rate | 9.45 | 20.92 | 21.43 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 61.90 |
| Operating Expense | 49.20 |
| Net Profit | 5.80 |
| Net Profit Margin | 9.37 |
| Earning Per Share | 0.36 |
| EBIDTA | 11.50 |
| Effective Tax Rate | 9.45 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 745.70 | 784.70 | 810.10 |
| Operating Expenses Annual | 713.60 | 768.20 | 807 |
| Operating Profit Annual | 120.50 | 119.90 | 141 |
| Interest Annual | 29.80 | 29.90 | 18.50 |
| Depreciation | 41.20 | 36.60 | 34.30 |
| Net Profit Annual | 19.20 | 31.60 | 49.90 |
| Tax Annual | 18.40 | 10.10 | 29.40 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 745.70 |
| Operating Expenses Annual | 713.60 |
| Operating Profit Annual | 120.50 |
| Interest Annual | 29.80 |
| Depreciation | 41.20 |
| Net Profit Annual | 19.20 |
| Tax Annual | 18.40 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 36.10 | 11 | 22.50 |
| Cash Flow from Operations | 135.60 | 143.20 | -65.10 |
| Cash Flow from Investing | -2.30 | -40.30 | 31.10 |
| Cash Flow from Financing | -156.80 | -77.80 | 22.50 |
| Cash Flow at the End | 12.60 | 36.10 | 11 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 36.10 |
| Cash Flow from Operations | 135.60 |
| Cash Flow from Investing | -2.30 |
| Cash Flow from Financing | -156.80 |
| Cash Flow at the End | 12.60 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 17.66 | 15.28 | 17.41 |
| PBIT Margin (%) | 10.54 | 9.12 | 12.07 |
| PBT Margin (%) | 10.19 | 8.82 | 11.42 |
| Net PROFIT Margin (%) | 2.57 | 4.03 | 6.16 |
| Return On Networth / Equity (%) | 1.04 | 1.32 | 2.06 |
| Return On Networth /Employed (%) | 2.88 | 2.57 | 3.60 |
| Return On Assets (%) | 0.70 | 1.13 | 1.85 |
| Total Debt / Equity (X) | 0.15 | 0.15 | 0.11 |
| Asset Turnover Ratio (%) | 0.27 | 0.28 | 0.30 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 17.66 |
| PBIT Margin (%) | 10.54 |
| PBT Margin (%) | 10.19 |
| Net PROFIT Margin (%) | 2.57 |
| Return On Networth / Equity (%) | 1.04 |
| Return On Networth /Employed (%) | 2.88 |
| Return On Assets (%) | 0.70 |
| Total Debt / Equity (X) | 0.15 |
| Asset Turnover Ratio (%) | 0.27 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 698.70 | 711.30 | 687.40 |
| Total Current Assets Annual | 484.20 | 540.60 | 578.80 |
| Non Current Assets Annual | 2,425.40 | 2,451.30 | 2,429.60 |
| Total Shareholders Funds Annual | 2,318.10 | 2,374.50 | 2,414.50 |
| Total Assets Annual | 2,909.60 | 2,991.90 | 3,008.40 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 698.70 |
| Total Current Assets Annual | 484.20 |
| Non Current Assets Annual | 2,425.40 |
| Total Shareholders Funds Annual | 2,318.10 |
| Total Assets Annual | 2,909.60 |
EPS (INR)
Expected
6.51
Reported
6.49
Surprise
-0.31%
Mar 2025
EPS beaten by -0.31%
Dec 2024
EPS beaten by -0.10%
Sep 2024
EPS beaten by -0.31%
